
The Dow’s Hidden Gem: How Amgen Is Standing Out in 2025’s Tumultuous Market
Amgen Inc. is emerging as a top-performing stock in the Dow Jones Industrial Average, with a year-to-date increase of over 12% in 2025. Key products include Repatha, a significant advancement in cholesterol management, and MariTide, a new monthly weight-loss drug, signaling innovation